| 2019 |
| 12/25 | 210 | 211 | 207 | 207 | -1.9% | 446,500 | 147億8122万 | -7.59% |
| 12/24 | 209 | 214 | 209 | 211 | +0.96% | 460,600 | 150億6685万 | -6.22% |
| 12/23 | 216 | 216 | 207 | 209 | -3.69% | 1,027,900 | 149億2215万 | -7.52% |
| 12/20 | 217 | 218 | 215 | 217 | 0% | 326,100 | 154億9334万 | -4.41% |
| 12/19 | 217 | 219 | 217 | 217 | -0.91% | 229,900 | 154億9334万 | -4.41% |
| 12/18 | 219 | 221 | 217 | 219 | 0% | 249,300 | 156億3613万 | -3.52% |
| 12/17 | 219 | 220 | 217 | 219 | +0.46% | 258,700 | 156億3613万 | -3.52% |
| 12/16 | 222 | 223 | 218 | 218 | -2.68% | 354,100 | 155億6474万 | -3.96% |
| 12/13 | 229 | 229 | 223 | 224 | -2.18% | 390,500 | 159億9312万 | -1.32% |
| 12/12 | 230 | 231 | 226 | 229 | -0.43% | 298,400 | 163億5240万 | +0.88% |
| 12/11 | 231 | 233 | 227 | 230 | +0.44% | 264,900 | 164億2381万 | +1.32% |
| 12/10 | 226 | 231 | 226 | 229 | +1.78% | 400,300 | 163億5240万 | +0.88% |
| 12/09 | 226 | 226 | 223 | 225 | +0.45% | 103,500 | 160億6677万 | -0.88% |
| 12/06 | 225 | 226 | 223 | 224 | -0.44% | 140,900 | 159億9536万 | -0.88% |
| 12/05 | 227 | 228 | 225 | 225 | -0.44% | 154,200 | 160億6677万 | -0.88% |
| 12/04 | 228 | 228 | 225 | 226 | -0.88% | 228,200 | 161億3818万 | -0.44% |
| 12/03 | 227 | 230 | 226 | 228 | -0.87% | 193,800 | 162億8099万 | +0.44% |
| 12/02 | 230 | 232 | 227 | 230 | +0.44% | 334,400 | 164億2381万 | +1.77% |
| 11/29 | 234 | 235 | 229 | 229 | -1.72% | 303,900 | 163億5240万 | +1.33% |
| 11/28 | 236 | 237 | 233 | 233 | -0.43% | 185,700 | 166億3803万 | +3.1% |
| 11/27 | 233 | 238 | 231 | 234 | 0% | 517,800 | 167億944万 | +4% |
| 11/26 | 232 | 234 | 231 | 234 | +0.86% | 219,900 | 167億944万 | +4% |
| 11/25 | 229 | 234 | 229 | 232 | +0.87% | 272,100 | 165億6663万 | +3.57% |
| 11/22 | 229 | 231 | 225 | 230 | +0.44% | 233,000 | 164億2381万 | +2.68% |
| 11/21 | 235 | 235 | 224 | 229 | -2.14% | 498,700 | 163億4130万 | +2.69% |
| 11/20 | 229 | 235 | 228 | 234 | +1.74% | 654,000 | 166億9809万 | +4.93% |
| 11/19 | 229 | 230 | 226 | 230 | +0.88% | 240,700 | 164億1265万 | +3.6% |
| 11/18 | 222 | 230 | 222 | 228 | +3.64% | 517,500 | 162億6994万 | +2.7% |
| 11/15 | 215 | 222 | 215 | 220 | +2.8% | 246,000 | 156億9906万 | -0.9% |
| 11/14 | 218 | 221 | 214 | 214 | -1.38% | 246,600 | 152億7090万 | -3.6% |
| 11/13 | 15:00 営業外費用の計上に関するお知らせ |
| 11/13 | 15:00 2020年3月期第2四半期決算短信〔日本基準〕(連結) |
| 11/13 | 222 | 222 | 215 | 217 | -2.25% | 340,000 | 154億8498万 | -2.25% |
| 11/12 | 15:00 再生医療製品ステムカイマルの第II相臨床試験に関する名古屋大学との治験契約締結のお知らせ |
| 11/12 | 223 | 224 | 220 | 222 | -0.89% | 176,300 | 158億4178万 | -0.45% |
| 11/11 | 223 | 224 | 222 | 224 | +0.9% | 96,300 | 159億8450万 | +0.45% |
| 11/08 | 226 | 228 | 222 | 222 | -1.77% | 203,900 | 158億4178万 | -0.89% |
| 11/07 | 15:00 A.N.H. Scientific Marketing Co.Ltd. とのタイにおける販売業務提携のお知らせ |
| 11/07 | 226 | 230 | 224 | 226 | +0.44% | 223,500 | 161億2722万 | +0.89% |
| 11/06 | 224 | 225 | 221 | 225 | +0.45% | 172,400 | 160億5586万 | +0.45% |
| 11/05 | 224 | 224 | 221 | 224 | +0.9% | 186,900 | 159億8450万 | 0% |
| 11/01 | 226 | 226 | 220 | 222 | -1.33% | 195,000 | 158億60万 | -0.89% |
| 10/31 | 226 | 228 | 225 | 225 | -0.88% | 217,100 | 160億1412万 | +0.45% |
| 10/30 | 226 | 228 | 225 | 227 | +0.89% | 295,400 | 161億5647万 | +1.34% |
| 10/29 | 224 | 227 | 224 | 225 | +0.45% | 293,200 | 160億1412万 | +0.9% |
| 10/28 | 222 | 228 | 221 | 224 | +1.36% | 200,500 | 159億4295万 | +0.45% |
| 10/25 | 224 | 226 | 221 | 221 | -0.9% | 245,600 | 157億2942万 | -0.45% |
| 10/24 | 15:00 連結子会社(REPROCELL USA Inc.)に対する補助金の交付決定に関するお知らせ |
| 10/24 | 223 | 224 | 221 | 223 | -0.45% | 147,900 | 158億7177万 | +0.45% |
| 10/23 | 218 | 225 | 217 | 224 | +2.75% | 300,900 | 159億4295万 | +1.36% |
| 10/21 | 218 | 218 | 216 | 218 | -0.46% | 172,800 | 155億1590万 | -1.36% |
| 10/18 | 216 | 219 | 215 | 219 | +0.92% | 222,800 | 155億8708万 | -0.9% |
| 10/17 | 219 | 221 | 217 | 217 | -1.36% | 191,200 | 154億4473万 | -1.36% |
| 10/16 | 221 | 222 | 220 | 220 | 0% | 138,100 | 156億5825万 | 0% |
| 10/15 | 218 | 221 | 217 | 220 | +1.38% | 146,900 | 156億5825万 | 0% |
| 10/11 | 216 | 219 | 215 | 217 | -0.46% | 162,500 | 154億4473万 | -0.91% |
| 10/10 | 15:00 分担企業として参加するAMED公募事業の2018年度補助金交付額確定に関するお知らせ |
| 10/10 | 224 | 224 | 216 | 218 | -2.68% | 327,700 | 155億1590万 | -0.46% |
| 10/09 | 226 | 228 | 224 | 224 | -2.18% | 275,700 | 159億4295万 | +2.75% |
| 10/08 | 230 | 230 | 225 | 229 | +0.44% | 382,900 | 162億9882万 | +5.05% |
| 10/07 | 236 | 236 | 228 | 228 | -2.15% | 300,700 | 162億2764万 | +5.07% |
| 10/04 | 11:30 (訂正)「譲渡制限付株式報酬としての新株式発行に関するお知らせ」の一部訂正について |
| 10/04 | 228 | 233 | 226 | 233 | +2.64% | 286,800 | 165億8351万 | +7.87% |
| 10/03 | 15:00 譲渡制限付株式報酬としての新株式発行に関するお知らせ |
| 10/03 | 231 | 232 | 225 | 227 | -3.81% | 529,500 | 161億5647万 | +6.07% |
| 10/02 | 228 | 236 | 228 | 236 | +3.96% | 536,300 | 167億9703万 | +10.28% |
| 10/01 | 17:00 北米及びヨーロッパにおけるNeuCyte社製品に関する販売代理店契約締結に関するお知らせ |
| 10/01 | 236 | 237 | 227 | 227 | -2.58% | 699,200 | 161億5647万 | +7.08% |
| 09/30 | 229 | 236 | 229 | 233 | +1.75% | 657,700 | 165億8351万 | +9.91% |
| 09/27 | 223 | 229 | 220 | 229 | +3.62% | 922,600 | 162億9882万 | +8.53% |
| 09/26 | 215 | 223 | 215 | 221 | +3.76% | 732,200 | 157億2942万 | +4.74% |
| 09/25 | 215 | 217 | 212 | 213 | -1.84% | 318,000 | 151億6003万 | +0.95% |
| 09/24 | 215 | 220 | 215 | 217 | +1.88% | 453,200 | 154億4473万 | +2.84% |
| 09/20 | 213 | 215 | 212 | 213 | 0% | 216,800 | 151億5908万 | +1.43% |
| 09/19 | 213 | 216 | 213 | 213 | -0.47% | 178,900 | 151億5908万 | +1.43% |
| 09/18 | 213 | 215 | 212 | 214 | +0.94% | 168,200 | 152億3024万 | +1.9% |
| 09/17 | 211 | 213 | 210 | 212 | 0% | 294,700 | 150億8791万 | +0.95% |
| 09/13 | 212 | 214 | 210 | 212 | -0.93% | 407,600 | 150億8791万 | +0.47% |
| 09/12 | 219 | 224 | 214 | 214 | +0.47% | 1,177,100 | 152億3024万 | +0.94% |
| 09/11 | 15:00 上海拜力生物科技有限会社との中国における販売業務提携のお知らせ |
| 09/11 | 211 | 213 | 209 | 213 | +1.43% | 327,200 | 151億5908万 | +0.47% |
| 09/10 | 219 | 220 | 210 | 210 | +0.96% | 621,000 | 149億4557万 | -1.41% |
| 09/09 | 15:00 Axion BioSystems社との国内における販売代理店契約締結に関するお知らせ |
| 09/09 | 211 | 211 | 207 | 208 | -2.35% | 311,500 | 148億323万 | -2.8% |
| 09/06 | 207 | 214 | 207 | 213 | +2.9% | 439,000 | 151億5908万 | -0.47% |
| 09/05 | 209 | 210 | 207 | 207 | +0.98% | 365,700 | 147億3206万 | -3.72% |
| 09/04 | 208 | 208 | 205 | 205 | -1.44% | 170,100 | 145億8972万 | -5.09% |
| 09/03 | 15:00 合弁会社Fox Chase Bioserve Pvt.Ltd.（インド）の開所式を開催いたしました |
| 09/03 | 206 | 208 | 205 | 208 | 0% | 221,700 | 148億323万 | -4.15% |
| 09/02 | 206 | 209 | 204 | 208 | -1.42% | 411,300 | 148億323万 | -5.02% |
| 08/30 | 202 | 211 | 200 | 211 | +7.65% | 638,500 | 150億1674万 | -4.09% |
| 08/29 | 200 | 202 | 196 | 196 | -2% | 369,700 | 139億4920万 | -11.31% |
| 08/28 | 206 | 206 | 200 | 200 | -3.38% | 433,000 | 142億3387万 | -9.91% |
| 08/27 | 209 | 210 | 205 | 207 | -0.48% | 254,800 | 147億3206万 | -7.59% |
| 08/26 | 210 | 211 | 207 | 208 | -3.26% | 342,600 | 148億323万 | -7.56% |
| 08/23 | 216 | 218 | 214 | 215 | -1.83% | 228,400 | 153億141万 | -4.87% |
| 08/22 | 222 | 223 | 216 | 219 | +2.34% | 700,700 | 155億8609万 | -3.1% |
| 08/21 | 15:00 当社と順天堂大学による共同事業のNEDO公募事業への採択に関するお知らせ |
| 08/21 | 214 | 216 | 211 | 214 | -0.47% | 214,200 | 152億2596万 | -5.73% |
| 08/20 | 212 | 215 | 212 | 215 | +1.42% | 266,200 | 152億9711万 | -5.29% |
| 08/19 | 209 | 214 | 208 | 212 | +0.95% | 154,500 | 150億8367万 | -7.02% |
| 08/16 | 207 | 210 | 207 | 210 | +0.96% | 266,100 | 149億4137万 | -8.3% |
| 08/15 | 208 | 208 | 203 | 208 | -2.35% | 564,400 | 147億9907万 | -9.96% |
| 08/14 | 220 | 220 | 212 | 213 | -2.74% | 288,400 | 151億5482万 | -8.19% |
| 08/13 | 213 | 219 | 211 | 219 | -4.37% | 554,300 | 155億8171万 | -6.01% |
| 08/09 | 15:00 営業外費用の計上に関するお知らせ |
| 08/09 | 15:00 2020年3月期第1四半期決算短信〔日本基準〕(連結) |
| 08/09 | 235 | 235 | 228 | 229 | -0.43% | 182,500 | 162億9321万 | -2.14% |
| 08/08 | 230 | 232 | 228 | 230 | 0% | 158,300 | 163億6435万 | -1.71% |
| 08/07 | 232 | 234 | 229 | 230 | -0.86% | 164,600 | 163億6435万 | -1.71% |
| 08/06 | 215 | 232 | 215 | 232 | +4.04% | 397,200 | 165億665万 | -0.85% |
| 08/05 | 225 | 226 | 217 | 223 | -1.76% | 468,100 | 158億6631万 | -4.7% |
| 08/02 | 230 | 231 | 226 | 227 | -2.58% | 255,500 | 161億5091万 | -2.99% |
| 08/01 | 232 | 236 | 232 | 233 | -0.43% | 198,000 | 165億7780万 | -0.43% |
| 07/31 | 235 | 237 | 233 | 234 | -0.85% | 132,500 | 166億4895万 | +0.43% |
